Dow slides 391 points on reports Moderna's COVID-19 vaccine study lacked key data

1:07pm PDT - May 19th, 2020    dow jones - Business Insider

• US indexes slid in late trading on Tuesday amid reports that Moderna's highly touted coronavirus vaccine study lacked key data.
• It marked a reversal from the Dow Jones industrial average's 912-point surge on Monday after positive results fro…